About Synexa Life Sciences
Synexa Life Sciences is a company based in Cape Town (South Africa) founded in 2003. Synexa Life Sciences has completed 2 acquisitions, including Alderley Analytical and Syrinx Bioanalytics. Synexa Life Sciences offers products and services including Translational Flow Cytometry, ELISpot Biomarkers, Clinical Bioanalysis, Radiopharmaceutical Bioanalysis, and Genomics. Synexa Life Sciences operates in a competitive market with competitors including Omniome, HitGen, Rejuvenate Bio, Novogene Corporation and BioAgilytix, among others.
- Headquarter Cape Town, South Africa
- SectorsHealthcare
- Phone•••• ••••
- Website synexagroup.com
- Social LinkedIn YouTube
- Legal Name Synexa Life Sciences Bv
- Investments & AcquisitionsAlderley Analytical
& 1 more
Products & Services of Synexa Life Sciences
Synexa Life Sciences offers a comprehensive portfolio of products and services, including Translational Flow Cytometry, ELISpot Biomarkers, Clinical Bioanalysis, Radiopharmaceutical Bioanalysis, and Genomics.
Develops and validates assays for immune cell analysis in trials.
Detects antigen-specific immune responses for disease research.
Analyzes large molecules for clinical sample testing.
Supports radiopharmaceutical development for therapies.
Provides precise assays for genetic analysis in research.
Apps and channels of Synexa Life Sciences
its YouTube channel Synexa Life Sciences has 15 subscribers and 9 videos.
Videos from Synexa Life Sciences
The most watched videos on Synexa Life Sciences's YouTube channel, Synexa Life Sciences (15 subscribers). Click a video to play it here.
More on Synexa Life Sciences.
People of Synexa Life Sciences
14 people are tracked at Synexa Life Sciences (12 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Grace Loxley | Associate Director Business Development | Leadership |
Claire Jenkins | Chief Commercial Officer | Leadership |
Matt Goodwin | Account Director, Key Accounts | Leadership |
Justin Devine | Chief Innovation Officer | Leadership |
Emile Lens | CEO And Co Owner | Leadership |
Elizabeth Ross | Head Of Business Operations | Leadership |
James Lloyd | Chief Financial Officer | Leadership |
Grégoire Tauveron | Business Development Director | Leadership |
Melanie Lucas | Global Head Of Operations | Leadership |
Francois Botha | Head Of Business Information | Leadership |
Paula Thornton | CHRO (chief Human Resources Officer) | Leadership |
Beatriz Gómez | Strategy Director | Leadership |
Stefan Docherty | Marketing Manager | Team |
Faeza Isaacs | Global Sales Operations, Projects Office & Company Secretary | Team |
Complete people profiles for Synexa Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synexa Life Sciences
Synexa Life Sciences has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Alderley Analytical and Syrinx Bioanalytics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Bioanalytical assays for drug development are developed and validated. | alderleyanalytical.com | Stockport, United Kingdom | 2013 | Oct 2024 | •••• | |
Bioanalytical immunoassay services for biologics and biomarkers are provided. | syrinxbioanalytics.com | Turku, Finland | 2007 | May 2022 | •••• |
Complete acquisition details for Synexa Life Sciences
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Synexa Life Sciences
3 dated milestones of Synexa Life Sciences across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Synexa Life Sciences is founded.
- Acquisition Acquires Syrinx Bioanalytics.
- Acquisition Acquires Alderley Analytical.
Competitors of Synexa Life Sciences
Synexa Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, HitGen, Rejuvenate Bio, Novogene Corporation and BioAgilytix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| hitgen.com | 2012 | Lanzhou, China | $39.11M | – | DNA-encoded libraries are developed for drug discovery applications. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| novogene.com | 2011 | Beijing, China | $75M | 141 | Genomic services and solutions with NGS expertise are provided. | |
| bioagilytix.com | 2008 | Durham, United States | – | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | |
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| novellusdx.com | 2011 | Jerusalem, Israel | $85.5M | – | Developer of technology for precision cancer diagnosis and therapies | |
| clinical-microbiomics.com | 2016 | Horsholm, Denmark | $9.71M | 35 | Meta-genomics platforms and services for microbiome studies are provided. | |
| bgi.com | 1999 | Shenzhen, China | – | 25 | BGI is engaged in genomics and precision medicine solutions. | |
| genewiz.com | 1999 | South Plainfield, United States | – | 452 | Genomic services are provided for the life sciences industry. |
Detailed competitors of Synexa Life Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Synexa Life Sciences
The website of Synexa Life Sciences (synexagroup.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 6.3% vs previous month
Latest news on Synexa Life Sciences
Complete news archive for Synexa Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Synexa Life Sciences
10 companies that operate in the same segment as Synexa Life Sciences (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Synexa Life Sciences
Synexa Life Sciences was founded in 2003.
Synexa Life Sciences is headquartered in Cape Town, South Africa. It is registered at Cape Town, Western Cape, South Africa.
Synexa Life Sciences offers analytical and advisory services to pharma and biotech companies mainly in the development and analysis of biomarkers in clinical trials and diagnostic validation programs. They help companies in formulating a biomarker strategy, assay development and validation, sample analysis and also by offering bioinformatics solutions. Their proprietary approach called ProtoTrials is an in vitro translational immunology study conducted on human samples (both healthy and patient volunteers) that can offer insights into the efficacy, safety and MOA of a drug. Their assay portfolio includes immunoassays, flow cytometry,culture based assays, liquid biopsies and lymphosure (QA standard for flow cytometric analysis of lymphocyte subsets). Synexa also offers bioanalytical chemistry and genotyping and gene expression profiling services.
Synexa Life Sciences's top competitors include Novogene Corporation, BGI and BioAgilytix.
Synexa Life Sciences offers Translational Flow Cytometry, ELISpot Biomarkers, Clinical Bioanalysis, Radiopharmaceutical Bioanalysis, and Genomics.
Synexa Life Sciences has made 2 acquisitions, including Alderley Analytical, and Syrinx Bioanalytics.
Synexa Life Sciences operates through Synexa Life Sciences Bv.